Baillie Gifford Worldwide Health Innovation Fund Class A Fonds
6,87
EUR
+0,03
EUR
+0,43
%
NAV
Werbung
Der Fonds Baillie Gifford Worldwide Health Innovation Fund Class A EUR Acc Fonds wird seit dem 13.11.2024 nicht mehr vertrieben. Nähere Informationen erhalten sie von der Fondsgesellschaft.
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| argenx SE | NL0010832176 | 7,62% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 7,12% |
| Alk-Abello AS Class B | DK0061802139 | 5,64% |
| Ambu AS Class B | DK0060946788 | 5,13% |
| Genmab AS | DK0010272202 | 4,43% |
| Insulet Corp | US45784P1012 | 4,28% |
| Exact Sciences Corp | US30063P1057 | 4,09% |
| ResMed Inc | US7611521078 | 3,90% |
| Moderna Inc | US60770K1079 | 3,74% |
| Doximity Inc Class A | US26622P1075 | 3,63% |
| Sonstige | 50,42% |